All In MedTech

Device Trial Radar · NCT06686485

Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia

Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

433

Planned (sponsor's estimate)

Start

Mar 18, 2025

Primary completion

Oct 31, 2026

Study completion Oct 31, 2029

Sponsor

Lead sponsor
Boston Scientific CorporationPublic (BSX)
Sponsor type
Industry
First posted
Nov 13, 2024

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Subjects enrolled in the OPTION-A study will be clinically indicated for atrial fibrillation (AF) ablation procedure with the FARAPULSE™ PFA system and treatment with WATCHMAN LAAC Device, per physician's medical judgement and according to hospitals' standard of care during the same procedure.

Conditions

  • Concomitant Procedures
  • Atrial Fibrillation
  • PFA
  • LAAC

Interventions

  • FARAPULSE™ PFA system and WATCHMAN LAAC Delivery SystemsDevice

    The FARAPULSE™ PFA System consists of the FARAWAVE™ Pulsed Field Ablation Catheter, the FARASTAR™ Pulsed Field Ablation Generator, and the FARADRIVE™ Steerable Sheath. The WATCHMAN LAA Closure Technology consists of the WATCHMAN Access System (which consists of the Access Sheath and Dilator and the WATCHMAN Delivery System (which consists of the delivery catheter and the pre-loaded closure device). The WATCHMAN Access System and WATCHMAN Delivery System permit device placement in the LAA via femoral venous access and crossing the inter-atrial septum into the left atrium.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Periprocedural or procedure-related Composite Serious Adverse Events will be assessedTime frame: 30 days post index procedure
  2. Acute Treatment Success will be assessedTime frame: between index procedure and 30 days post index procedure

Locations

37 sites in 6 countries. Site status is shown where the registry gives one.

  • Beijing Anzhen Hospital of the Capital University of Medical Sciences

    Beijing, China

  • Xuanwu Hospital Capital Medical University

    Beijing, China

  • Huaxi Hospital of Sichuan University

    Chengdu, China

34 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.